Jan-Frens van Giessel

Jan-Frens van Giessel is an experienced professional in the fields of investment and board governance, currently serving as a Board Member at Honic since October 2023 and a Partner at Holland Capital since March 2018. Van Giessel holds board positions at several organizations including Sirius Medical, HealthConnected (NL), Kriya Materials B.V., and NightWatch Epilepsy Detection. Additionally, van Giessel is a member of the Investment Committee for both the First Fund and the RedMedTech Discovery Fund. Previous roles include Board Member at Xilloc and Shareholder Representative at Ventinova Medical. Jan-Frens van Giessel earned a Master of Science in Science and Innovation Management from Utrecht University and completed VWO at De Heemgaard in Apeldoorn.